Daniel Bensen Biography and Net Worth

COO of Tyra Biosciences

Daniel Bensen is Chief Operating Officer of Tyra which he co-founded in August 2018. Prior to co-founding Tyra, Dan served as Head of Immunology and Protein Chemistry at Cidara Therapeutics, Inc. where he led cross functional research groups pioneering a novel immunotherapeutic platform resulting in two candidates. Before Cidara, Dan served as Principal Scientist, Protein Chemistry and Structural Biology at Trius Therapeutics, Inc where he oversaw efforts to generate and advance a novel class of dual-targeting broad spectrum antibacterial agents until its acquisition by Cubist Pharmaceuticals. Before Trius, Dan held positions of increasing responsibility in structural biology and protein chemistry at ActiveSight and Diversa. Dan holds a B.A. in Biology from Point Loma Nazarene University and an M.B.A. from the University of Southern California, Marshall School of Business.

What is Daniel Bensen's net worth?: The estimated net worth of Daniel Bensen is at least $9.54 million as of June 7th, 2024. Bensen owns 431,483 shares of Tyra Biosciences stock worth more than $9,540,089 as of December 4th. This net worth approximation does not reflect any other investments that Bensen may own. Additionally, Bensen receives a salary of $630,800.00 as COO at Tyra Biosciences. Learn More about Daniel Bensen's net worth.
How old is Daniel Bensen?: Bensen is currently 48 years old. There are 6 older executives and no younger executives at Tyra Biosciences. The oldest executive at Tyra Biosciences is Dr. Robert L. Hudkins Ph.D., Chief Technology Officer, who is 68 years old. Learn More on Daniel Bensen's age.
What is Daniel Bensen's salary?: As the COO of Tyra Biosciences, Inc., Bensen earns $630,800.00 per year. There are 3 executives that earn more than Bensen. The highest earning executive at Tyra Biosciences is Dr. Todd Harris Ph.D., Co-Founder, President, CEO, Secretary, Treasurer & Director, who commands a salary of $1,070,000.00 per year. Learn More on Daniel Bensen's salary.
How do I contact Daniel Bensen?: The corporate mailing address for Bensen and other Tyra Biosciences executives is 2656 STATE STREET, CARLSBAD CA, 92008. Tyra Biosciences can also be reached via phone at 619-728-4760 and via email at [email protected].. Learn More on Daniel Bensen's contact information.
Has Daniel Bensen been buying or selling shares of Tyra Biosciences?: Daniel Bensen has not been actively trading shares of Tyra Biosciences during the past quarter. Most recently, Daniel Bensen sold 3,502 shares of the business's stock in a transaction on Monday, June 10th. The shares were sold at an average price of $20.00, for a transaction totalling $70,040.00. Following the completion of the sale, the chief operating officer now directly owns 427,981 shares of the company's stock, valued at $8,559,620. Learn More on Daniel Bensen's trading history.
Who are Tyra Biosciences' active insiders?: Tyra Biosciences' insider roster includes Daniel Bensen (COO), Alan Fuhrman (CFO), Todd Harris (CEO), and Gilla Kaplan (Director). Learn More on Tyra Biosciences' active insiders.
Are insiders buying or selling shares of Tyra Biosciences?: In the last twelve months, insiders at the sold shares 10 times. They sold a total of 330,261 shares worth more than $5,972,313.26. The most recent insider tranaction occured on November, 21st when Director Robert J More sold 246,871 shares worth more than $4,999,137.75. Insiders at Tyra Biosciences own 15.2% of the company. Learn More about insider trades at Tyra Biosciences.
Information on this page was last updated on 11/21/2025.

Daniel Bensen Insider Trading History at Tyra Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/10/2024	Sell	3,502	$20.00	$70,040.00	427,981
6/7/2024	Sell	200	$20.00	$4,000.00	431,483
3/11/2024	Sell	200	$20.00	$4,000.00	431,683
3/6/2024	Sell	1,733	$20.09	$34,815.97	431,951
2/29/2024	Sell	2,050	$20.00	$41,000.00	442,836
2/27/2024	Sell	745	$20.00	$14,900.00	450,735
2/12/2024	Sell	1,501	$20.00	$30,020.00	451,480
2/7/2024	Sell	9,587	$18.09	$173,428.83	452,981
7/21/2023	Sell	3,900	$16.01	$62,439.00	527,981
7/19/2023	Sell	207	$16.07	$3,326.49	527,981
7/17/2023	Sell	1,900	$16.03	$30,457.00	527,981
7/13/2023	Sell	500	$16.13	$8,065.00	527,981
7/11/2023	Sell	500	$16.02	$8,010.00	527,981
7/3/2023	Sell	4,265	$16.37	$69,818.05	527,981
6/30/2023	Sell	18,819	$16.97	$319,358.43	527,981
6/27/2023	Sell	16,028	$16.91	$271,033.48	527,981
6/14/2023	Sell	120	$16.45	$1,974.00	527,981
4/3/2023	Sell	2,000	$16.16	$32,320.00	527,981
3/31/2023	Sell	400	$16.00	$6,400.00	527,981
3/29/2023	Sell	2,187	$16.21	$35,451.27	527,981
3/27/2023	Sell	8,048	$16.00	$128,768.00	527,981
3/22/2023	Sell	3,800	$16.00	$60,800.00	527,981

Daniel Bensen Buying and Selling Activity at Tyra Biosciences

Tyra Biosciences Company Overview

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Today's Range

Now: $22.11

$21.43

$22.13

50 Day Range

MA: $16.14

$12.97

$22.51

2 Week Range

Now: $22.11

$6.42

$22.83

Volume

916,903 shs

Average Volume

466,587 shs

Market Capitalization

$1.18 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Daniel Bensen Biography and Net Worth

What is Daniel Bensen's net worth?

How old is Daniel Bensen?

What is Daniel Bensen's salary?

How do I contact Daniel Bensen?

Has Daniel Bensen been buying or selling shares of Tyra Biosciences?

Who are Tyra Biosciences' active insiders?

Are insiders buying or selling shares of Tyra Biosciences?